CN109123626A - 一种糖尿人群食用粥类的配方及制备方法 - Google Patents
一种糖尿人群食用粥类的配方及制备方法 Download PDFInfo
- Publication number
- CN109123626A CN109123626A CN201810966267.4A CN201810966267A CN109123626A CN 109123626 A CN109123626 A CN 109123626A CN 201810966267 A CN201810966267 A CN 201810966267A CN 109123626 A CN109123626 A CN 109123626A
- Authority
- CN
- China
- Prior art keywords
- grams
- milligrams
- vitamin
- glycosuria
- lactate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021395 porridge Nutrition 0.000 title claims abstract description 15
- 206010018473 Glycosuria Diseases 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 238000009472 formulation Methods 0.000 title abstract description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- 108010011485 Aspartame Proteins 0.000 claims abstract description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 8
- 239000000605 aspartame Substances 0.000 claims abstract description 8
- 235000010357 aspartame Nutrition 0.000 claims abstract description 8
- 229960003438 aspartame Drugs 0.000 claims abstract description 8
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 7
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 7
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 7
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 7
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 7
- 244000075850 Avena orientalis Species 0.000 claims abstract description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 7
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract description 7
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 7
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 7
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 7
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 7
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 7
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 7
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims abstract description 7
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 7
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 7
- 239000001527 calcium lactate Substances 0.000 claims abstract description 7
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000020232 peanut Nutrition 0.000 claims abstract description 7
- 235000018102 proteins Nutrition 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 229960002477 riboflavin Drugs 0.000 claims abstract description 7
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 7
- 229960003495 thiamine Drugs 0.000 claims abstract description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 7
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 7
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 7
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 7
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 7
- 239000011718 vitamin C Substances 0.000 claims abstract description 7
- 235000010447 xylitol Nutrition 0.000 claims abstract description 7
- 229960002675 xylitol Drugs 0.000 claims abstract description 7
- 239000000811 xylitol Substances 0.000 claims abstract description 7
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 7
- 229940050168 zinc lactate Drugs 0.000 claims abstract description 7
- 235000000193 zinc lactate Nutrition 0.000 claims abstract description 7
- 239000011576 zinc lactate Substances 0.000 claims abstract description 7
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 235000021329 brown rice Nutrition 0.000 claims abstract description 6
- 229940037907 ferrous lactate Drugs 0.000 claims abstract description 6
- 235000013925 ferrous lactate Nutrition 0.000 claims abstract description 6
- 239000004225 ferrous lactate Substances 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 240000008669 Hedera helix Species 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 6
- 239000008103 glucose Substances 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 5
- 235000005911 diet Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种糖尿人群食用粥类的配方及制备方法，包括：苦荞30—40克、莜麦20—30克、糙米20克—30克、大豆蛋白或者花生蛋白10—20克、薏仁米5—10克、葛根5—10克、淮山药5—10克、白扁豆5—10克、麦芽糊精5—10克、木糖醇2—5克、乳酸钙200—700毫克、乳酸亚铁4—8毫克、乳酸锌4—11毫克、维生素B1:1—1.75毫克、维生素B2:1—1.75毫克、维生素C:30—75毫克、阿斯巴甜。本发明通过发明一种糖尿人群食用粥类的配方及制备方法实现患者对血糖和血脂的稳定性控制。
Description
技术领域
本发明涉及一种保健食品，尤其是一种糖尿人群食用粥类的配方及制备方法。
背景技术
目前糖尿病患者逐年增加，糖尿病分为1型和2型，前者患病少，病程短，对胰岛素治疗效果好；而后者患病率高，病程长，有严重的合并症，对胰岛素等治疗效果差，要想控制好病情，除了积极治疗，还要避免常犯的一些错误。专家提醒，血糖和血脂控制不佳的患者不妨从自己身上找找原因。美国俄勒冈卫生与科技大学糖尿病健康中心主任安德鲁·阿曼博士表示，糖尿病患者看医生的时间是有限的，在99.9％的时间里，糖友是自己的“医生”。如果不了解糖尿病，不了解自己的身体状况，饮食、锻炼、吃药的效果就会打折扣。不控制饮食。饮食治疗是糖尿病治疗的基础，其目的是减轻胰岛β细胞的负担，以帮助其恢复功能。有的人认为吃降糖药了就不用控制饮食，大吃大喝，甚至大量饮酒。还有的人错误地认为控制饮食，生活就没有质量了，其结果必然是血糖和血脂长期居高不下。并且传统的粥类食品中含有淀粉较多，患者食用后极易造成血糖快速升高威胁生命的情况。
因此，设计出一种糖尿人群食用粥类的配方及制备方法是业界亟待解决的问题。
发明内容
本发明提供一种糖尿人群食用粥类的配方，包括：苦荞30—40克、莜麦20—30克、糙米20克—30克、大豆蛋白或者花生蛋白10—20克、薏仁米5—10克、葛根5—10克、淮山药5—10克、白扁豆5—10克、麦芽糊精5—10克、木糖醇2—5克、乳酸钙200—700毫克、乳酸亚铁4—8毫克、乳酸锌4—11毫克、维生素B1:1—1.75毫克、维生素B2:1—1.75毫克、维生素C:30—75毫克、阿斯巴甜。
进一步地，所述阿斯巴甜含有苯丙氨酸。
本发明还提出一种糖尿人群食用粥类的制备方法，包括以下步骤：
步骤一:将苦荞、莜麦、糙米、大豆蛋白或者花生蛋白、薏仁米、葛根、淮山药、白扁豆、麦芽糊精加入适量的水并用温火熬粥；
步骤二：将木糖醇、乳酸钙、乳酸亚铁、乳酸锌、维生素B1、维生素B2、维生素C、阿斯巴甜溶解于水成溶液；
步骤三:将溶液加入熬粥即可。
与现有的技术相比，本发明具有以下优点：
通过发明一种糖尿人群食用粥类的配方及制备方法实现患者对血糖和血脂的稳定性控制。
具体实施方式
为了更充分理解本发明的技术内容，下面对本发明进一步进行说明，但不局限于此。
本发明提供一种糖尿人群食用粥类的配方，包括：苦荞35克、莜麦25克、糙米20克—30克、大豆蛋白或者花生蛋白15克、薏仁米7.5克、葛根7.5克、淮山药7.5克、白扁豆7.5克、麦芽糊精7.5克、木糖醇2.5克、乳酸钙500毫克、乳酸亚铁6毫克、乳酸锌6毫克、维生素B1:1.25毫克、维生素B2:1.25毫克、维生素C:55毫克、阿斯巴甜。
优选一实施例，阿斯巴甜含有苯丙氨酸。
其中，上述一种糖尿人群食用粥类的制备方法，包括以下步骤：
步骤一:将苦荞、莜麦、糙米、大豆蛋白或者花生蛋白、薏仁米、葛根、淮山药、白扁豆、麦芽糊精加入适量的水并用温火熬粥；
步骤二：将木糖醇、乳酸钙、乳酸亚铁、乳酸锌、维生素B1、维生素B2、维生素C、阿斯巴甜溶解于水成溶液；
步骤三:将溶液加入熬粥即可。
与现有的技术相比，本发明具有以下优点：
通过发明一种糖尿人群食用粥类的配方及制备方法实现患者对血糖和血脂的稳定性控制。
以上的具体实施例仅用以举例说明本发明的构思，本领域的普通技术人员在本发明的构思下可以做出多种变形和变化。这些变形和变化均包括在本发明的保护范围之内。
Claims (3)
1.一种糖尿人群食用粥类的配方，其特征在于，包括：苦荞30—40克、莜麦20—30克、糙米20克—30克、大豆蛋白或者花生蛋白10—20克、薏仁米5—10克、葛根5—10克、淮山药5—10克、白扁豆5—10克、麦芽糊精5—10克、木糖醇2—5克、乳酸钙200—700毫克、乳酸亚铁4—8毫克、乳酸锌4—11毫克、维生素B1:1—1.75毫克、维生素B2:1—1.75毫克、维生素C:30—75毫克、阿斯巴甜。
2.如权利要求1所述的糖尿病人群食用粥类的配方，其特征在于，所述阿斯巴甜含有苯丙氨酸。
3.一种糖尿人群食用粥类的制备方法，其特征在于，包括以下步骤：
步骤一:将苦荞、莜麦、糙米、大豆蛋白或者花生蛋白、薏仁米、葛根、淮山药、白扁豆、麦芽糊精加入适量的水并用温火熬粥；
步骤二：将木糖醇、乳酸钙、乳酸亚铁、乳酸锌、维生素B1、维生素B2、维生素C、阿斯巴甜溶解于水成溶液；
步骤三:将溶液加入熬粥即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810966267.4A CN109123626A (zh) | 2018-08-23 | 2018-08-23 | 一种糖尿人群食用粥类的配方及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810966267.4A CN109123626A (zh) | 2018-08-23 | 2018-08-23 | 一种糖尿人群食用粥类的配方及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109123626A true CN109123626A (zh) | 2019-01-04 |
Family
ID=64790997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810966267.4A Pending CN109123626A (zh) | 2018-08-23 | 2018-08-23 | 一种糖尿人群食用粥类的配方及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109123626A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101143010A (zh) * | 2006-09-15 | 2008-03-19 | 上海瑞品实业有限公司 | 糖尿病患者专用营养食品及其制备方法 |
| CN101507491A (zh) * | 2008-02-15 | 2009-08-19 | 韩忠民 | 食品营养强化复合营养素 |
| CN105285698A (zh) * | 2015-12-06 | 2016-02-03 | 重庆维可健康咨询有限公司 | 一种具有祛斑美肤功效的粥 |
| CN107897905A (zh) * | 2017-12-06 | 2018-04-13 | 刘文广 | 一种降糖营养粉及其制备方法和应用 |
-
2018
- 2018-08-23 CN CN201810966267.4A patent/CN109123626A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101143010A (zh) * | 2006-09-15 | 2008-03-19 | 上海瑞品实业有限公司 | 糖尿病患者专用营养食品及其制备方法 |
| CN101507491A (zh) * | 2008-02-15 | 2009-08-19 | 韩忠民 | 食品营养强化复合营养素 |
| CN105285698A (zh) * | 2015-12-06 | 2016-02-03 | 重庆维可健康咨询有限公司 | 一种具有祛斑美肤功效的粥 |
| CN107897905A (zh) * | 2017-12-06 | 2018-04-13 | 刘文广 | 一种降糖营养粉及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Batool et al. | Protein–energy malnutrition: A risk factor for various ailments | |
| US5994295A (en) | Therapeutic system for dietary health management | |
| US6039978A (en) | Dietary food enhancement agent | |
| CA2223056C (en) | Prepackaged therapeutic meal | |
| US20030143287A1 (en) | Nutritional supplement for the management of weight | |
| Greger | A whole food plant-based diet is effective for weight loss: The evidence | |
| WO1996039073A1 (en) | Method for determining diet program effectiveness | |
| EP0833571A2 (en) | Compliance support package for increasing health management system compliance | |
| Bajerska et al. | Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study | |
| Singh et al. | Effects of millet based functional foods rich diet on coronary risk factors among subjects with diabetes mellitus: a single arm real world observation from hospital registry | |
| CN109123619A (zh) | 一种供糖尿人群食用营养粉的配方及制备方法 | |
| Martirosyan et al. | Functional foods classification system: exemplifying through analysis of bioactive compounds | |
| Aberle et al. | Obesity and diabetes | |
| WO2013116062A1 (en) | Salt replacement compositions and methods of using same | |
| CN108835521A (zh) | 一种辅助糖尿人群调节血糖的特殊膳食配方及制备方法 | |
| CN109123626A (zh) | 一种糖尿人群食用粥类的配方及制备方法 | |
| CN107260996B (zh) | 一种均衡营养的肠内营养制剂 | |
| CN108522603A (zh) | 一种辅助调节血糖、血脂饼干的配方及其制备方法 | |
| CN108635516A (zh) | 一种调节血糖、血脂颗粒冲剂的配方及其制备方法 | |
| Goyal et al. | To study the Vitamin B12 status in morbidly obese patients | |
| CN108576230A (zh) | 一种辅助调节血糖、血脂奶粉的配方及制备方法 | |
| CN108719785A (zh) | 一种辅助调节血糖面条的配方及制备方法 | |
| WO2018042255A2 (en) | Nutritional compositions and methods of using same | |
| Chatvuttinun et al. | Development of food products using fish maw (Pangasius hypophthalmus) and roasted sunflower kernel (Helianthus annuus) for branched-chain organic acidurias patients. | |
| Qi et al. | Phenylketonuria and Dietary Carbohydrate–A review |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190104 |
|
| RJ01 | Rejection of invention patent application after publication |